Antiviral treatment for hepatitis C virus infection: Effectiveness at general population level in a highly endemic area
- 31 July 2009
- journal article
- clinical trial
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 41 (7), 509-515
- https://doi.org/10.1016/j.dld.2008.11.011
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Eligibility Criteria for Antiviral Therapy in HCV-Positive Patients: Similar Things to (Almost) Similar PeopleThe American Journal of Gastroenterology, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus InfectionThe American Journal of Gastroenterology, 2005
- Prevalence and etiology of altered liver tests: A population-based survey in a Mediterranean townHepatology, 2005
- Diagnosis, management, and treatment of hepatitis CHepatology, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis CAnnals of Internal Medicine, 2002
- Limited success of HCV antiviral therapy in United States veteransThe American Journal of Gastroenterology, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001